dr. kelly discusses the treatment of patients with alk nsclc
Published 5 years ago • 192 plays • Length 1:53Download video MP4
Download video MP3
Similar videos
-
1:30
dr. kelly on the outlook of alk-positive nsclc
-
2:12
dr. kelly on immunotherapy combinations for patients with nsclc
-
1:51
dr. camidge discusses treatment of patients with alk nsclc
-
1:14
dr. kelly on window-of-opportunity monotherapy trials in lung cancer
-
11:14
holistic management of patients with alk-positive nsclc
-
1:27
dr. ou on the use of crizotinib in patients with ros1-rearranged nsclc
-
22:10
first and second generation alk inhibitors for the treatment of lung cancer
-
1:11:31
dr. ou joins alktalk 11/17/2024
-
8:24
second-line treatment for alk-positive nsclc
-
8:24
second-line treatment for alk-positive nsclc
-
5:53
next-generation alk inhibitors in non-small cell lung cancer
-
1:28
dr. paik on the potential approval of lorlatinib for patients with alk-positive nsclc
-
1:07
dr. massarelli on first-line alk nsclc treatment
-
0:58
exploring treatment options for patients with alk-mutated lung cancer
-
0:44
dr. mark kris discusses crizotinib for patients with alk-positive lung cancer
-
4:08
treatment of alk-driven refractory nsclc
-
3:34
alk-positive nsclc: the role of treatment selection and sequencing
-
4:37
treatment of newly diagnosed alk-rearranged nsclc
-
0:56
dr. stinchcombe on the alta-1l trial in alk nsclc